Granata Francesco 4

4 · BIOGEN IDEC INC. · Filed Feb 3, 2011

Form 4

Period: 2011-02-01

EVP Global Commercial Operatio

Transactions

Exercise/Conversion
Common Stock
2011-02-01+821→ 4,286 total
Exercise/Conversion
Restricted Stock Unit
2011-02-01−821→ 16,506 total
Exercise: $0.00Exp: 2014-02-23→ Common Stock (821 underlying)
Tax Payment
Common Stock
2011-02-01$65.49/sh−1,124$73,611→ 3,162 total
Exercise/Conversion
Restricted Stock Unit
2011-02-01−3,465→ 17,327 total
Exercise: $0.00Exp: 2014-02-23→ Common Stock (3,465 underlying)
Exercise/Conversion
Common Stock
2011-02-01+3,465→ 3,465 total
Tax Payment
Common Stock
2011-02-01$65.49/sh−261$17,093→ 2,901 total
Other
Restricted Stock Unit
2011-02-01−912→ 15,594 total
Exercise: $0.00Exp: 2014-02-23→ Common Stock (0 underlying)

Footnotes (3)

[F1]There is no conversion or exercise price for this stock unit.
[F2]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 150% of the number of shares at target payout. One-fourth of these RSUs are eligible to vest on each of the first four anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen Idec common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the average 60 calendar-day closing stock price ending on the vesting date divided by the average 60 calendar-day closing stock price on the grant date]).
[F3]This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested.

Documents

2 files